A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study

by Nakai, Y, Isayama, H, Sasaki, T, Sasahira, N, Tsujino, T, Toda, N, Kogure, H, Matsubara, S, Ito, Y, Togawa, O, Arizumi, T, Hirano, K, Tada, M, Omata, M, Koike, K
Published 2012

Prognostic nomogram for nonresectable pancreatic cancer treated with gemcitabine-based chemotherapy

by Hamada, T, Nakai, Y, Yasunaga, H, Isayama, H, Matsui, H, Takahara, N, Sasaki, T, Takagi, K, Watanabe, T, Yagioka, H, Kogure, H, Arizumi, T, Yamamoto, N, Ito, Y, Hirano, K, Tsujino, T, Tada, M, Koike, K
Published 2014

A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer†

by Ueno, M., Okusaka, T., Omuro, Y., Isayama, H., Fukutomi, A., Ikeda, M., Mizuno, N., Fukuzawa, K., Furukawa, M., Iguchi, H., Sugimori, K., Furuse, J., Shimada, K., Ioka, T., Nakamori, S., Baba, H., Komatsu, Y., Takeuchi, M., Hyodo, I., Boku, N.
Published 2016

Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer

by Ohkawa, S, Okusaka, T, Isayama, H, Fukutomi, A, Yamaguchi, K, Ikeda, M, Funakoshi, A, Nagase, M, Hamamoto, Y, Nakamori, S, Tsuchiya, Y, Baba, H, Ishii, H, Omuro, Y, Sho, M, Matsumoto, S, Yamada, N, Yanagimoto, H, Unno, M, Ichikawa, Y, Takahashi, S, Watanabe, G, Wakabayashi, G, Egawa, N, Tsuda, M, Hosotani, R, Hamada, C, Hyodo, I
Published 2015